INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/16/2026
Back to search
Official data from USPTO
ALGRY SMART CHOLINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
01/17/2026
Trademark type
Combined
Nice classes
5
Filing date
07/04/2017
Registration date
10/30/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2025
Last transaction
01/17/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
ES
Examiner
BEVERLY,JOSETTE MICHELLE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ALGRY" in the color red and the wording "SMART CHOLINE" in the color purple underneath, a design a red circle with three concentric circles surrounding it as follows: first concentric circle in the color dark purple with the image of silhouette of a human head in the color dark gray with synapse in the color white, second concentric circle in the color purple with a design of three hands in the color dark gray embracing a liver in the color red, and third concentric circle in the color dark purple with a design of mother figure in the colors light brown and white holding a silhouette of infant's head in the color gray.
Holders and representatives
Holders
ALGRY QUIMICA, S.L.
Representatives
JOSE MARIA ARRUFAT ARRUFAT GRACIA PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for prenatal support and for the normal development of the brain and the development of the memory center in the uterus; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the development of the brain in infants; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the development of memory in children; pharmaceutical products productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the prevention of defects in the neural tube during fetal development; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for health and normal liver functions; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for promoting healthy heart conditions; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements to promote cerebral/cognitive health; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the health of the liver; pharmaceutical productspharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for sports nutrition; food for babies; disinfectants; sanitary preparations for medical use; dietetic foods and beverages adapted for medical use; food supplements for humans and animals; plasters for medical purposes; materials for dental fillings and dental impressions; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations and substances for the prevention and treatment of normal brain development and development of the memory center of prenatal in uterus during pregnancyfor the prevention and treatment of disease and disorders of brain and memory development in childrenfor the prevention of neural tube defects in fetal developmentfor prevention and treatment of diseases and disorders of liverfor prevention and treatment of diseases and disorders of heartfor prevention and treatment of diseases and disorders of brainfor the prevention of diseases and disorders of neural defects during fetal development; veterinary preparations for the prevention of diseases and disorders of brain during fetal development in pregnancy phase of animalsfor the prevention and treatment of diseases and disorders of brain in newborn animalsfor the prevention and treatment of diseases and disorders of liverheart and brain of animalsfor the prevention of neural diseases and neural disorders during fetal developmentfor its use as food supplement for animals; pharmaceutical preparations for health care for the prevention of brainliver and heart diseases; medicated serums for the treatment of brainliver and heart diseases; vaccines
Publications
History of USPTO decisions and trademark events.
34 publications found
C71T
CANCELLED SECTION 71
05/16/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/01/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/09/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/21/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/21/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2019
FIMP
FINAL DISPOSITION PROCESSED
02/07/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/14/2018
PUBO
PUBLISHED FOR OPPOSITION
08/14/2018
GPNX
NOTIFICATION PROCESSED BY IB
08/11/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/25/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/25/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/25/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2018
RFNT
REFUSAL PROCESSED BY IB
12/23/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/06/2017
RFRR
REFUSAL PROCESSED BY MPU
12/06/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/22/2017
CNRT
NON-FINAL ACTION WRITTEN
11/21/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/14/2017
DOCK
ASSIGNED TO EXAMINER
11/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/02/2017
Continuous trademark protection
Get notified about every new filing that threatens ALGRY SMART CHOLINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.